Open versus minimally invasive total gastrectomy after neoadjuvant chemotherapy: results of a European randomized trial

Abstract

These findings provide evidence that MITG after neoadjuvant therapy is not inferior regarding oncological quality of resection in comparison to OTG in Western patients with resectable gastric cancer. In addition, no differences in postoperative complications and recovery were seen.